InMed Pharmaceuticals Inc — Rendiconto Finanziario (NASDAQ:INM) | MetaTrader

Apri il grafico completo

Notizie

InMed Pharmaceuticals deposita prospetto integrativo per offerta di azioni

InMed riceve avviso di carenza del prezzo minimo di offerta dal Nasdaq

InMed presenta dati preclinici sul candidato farmaco per l’Alzheimer

InMed Pharmaceuticals Inc. (INM) Shareholder/Analyst Call Prepared Remarks Transcript

Why Intuit Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Gap (NYSE:GAP), Elastic (NYSE:ESTC)

Why Nvidia Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - Founder Group (NASDAQ:FGL), Cerence (NASDAQ:CRNC)

What's Driving InMed's (INM) 22% After-Hours Surge? - InMed Pharmaceuticals (NASDAQ:INM)

InMed’s Alzheimer’s drug candidate shows positive animal study results

InMed Pharmaceuticals appoints biotech veteran Neil Klompas to board

InMed Pharmaceuticals annuncia i dettagli per l’assemblea annuale 2025

InMed Pharmaceuticals announces details for 2025 annual shareholder meeting

Cognition Therapeutics Shares Jump 12% After Hours Following Encouraging Phase 2 Alzheimer's Trial Data - Cognition Therapeutics (NASDAQ:CGTX), InMed Pharmaceuticals (NASDAQ:INM)